Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Dare Bioscience (DARE) Return on Equity (2016 - 2025)

Dare Bioscience (DARE) has disclosed Return on Equity for 8 consecutive years, with 3.53% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Equity rose 4289.0% year-over-year to 3.53%, compared with a TTM value of 3.53% through Sep 2025, up 4289.0%, and an annual FY2024 reading of 4.24%, up 1444.0% over the prior year.
  • Return on Equity was 3.53% for Q3 2025 at Dare Bioscience, up from 1.66% in the prior quarter.
  • Across five years, Return on Equity topped out at 16.77% in Q3 2023 and bottomed at 45.35% in Q1 2021.
  • Average Return on Equity over 5 years is 4.88%, with a median of 0.95% recorded in 2022.
  • The sharpest move saw Return on Equity skyrocketed 4420bps in 2022, then plummeted -5612bps in 2024.
  • Year by year, Return on Equity stood at 1.11% in 2021, then crashed by -52bps to 1.68% in 2022, then surged by 603bps to 8.43% in 2023, then decreased by -25bps to 6.29% in 2024, then plummeted by -44bps to 3.53% in 2025.
  • Business Quant data shows Return on Equity for DARE at 3.53% in Q3 2025, 1.66% in Q2 2025, and 2.82% in Q1 2025.